Advertisement
Person › Details
Karen Linehan (Sanofi S.A. (Euronext: SAN, Nasdaq: SNY))
Linehan, Karen (Sanofi 201606– EVP Legal Affairs + General Counsel)
Organisation | Sanofi S.A. (Euronext: SAN, Nasdaq: SNY) | |
Group | Sanofi (Group) [since May 2011] | |
Product | pharmaceutical | |
Product 2 | legal services | |
Record changed: 2019-09-03 |
Advertisement
More documents for Karen Linehan
- [1] Sanofi S.A.. (8/28/19). "Press Release: U.S. District Court Invalidates Amgen Patent Claims Targeting PCSK9". Paris & Tarrytown, NY....
- [2] Sanofi S.A.. (1/5/17). "Press Release: Sanofi and Regeneron to Appeal U.S. District Court Rulings in Ongoing Patent Litigation Regarding Praluent (alirocumab) Injection". Paris & Tarrytown, NY....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top